| Item number | Description | Units per box |
|---|---|---|
| 72203012 | TruClear™ dense tissue shaver plus | 1 |
| 72204064 | TruClear™ dense tissue shaver mini | 1 |
Intrauterine tissue removal
TruClear™ dense tissue shaver
<p>The TruClear™ dense tissue shaver provides tissue removal in hysteroscopic procedures and comes in both a plus and a mini size.</p>
The TruClear™ tissue shaver technology
More options mean more control in every procedure.
When used with the TruClear™ system, our dense tissue shavers can provide complete pathology removal.1
Both TruClear™ dense tissue shavers offer:
- Simultaneous tissue cutting and aspiration to reduce procedure time†,2
- Proprietary suction control feature - suction is only activated while cutting is in progress
- 10 mm cutting window to aspirate greater volumes of tissue‡,3
| Name | TruClear™ dense tissue shaver mini | TruClear™ dense tissue shaver plus |
|---|---|---|
| Average tissue removal rate§ | 4.4 g/min4 (analog tissue) | 8.9 g/min5 (analog tissue) |
Ordering information
Related products
-
HysteroLux™ fluid management systemThe HysteroLux™ system enables uterine distention while monitoring a patient’s fluid deficit in real-time during hysteroscopic procedures.
-
TruClear™ 5C hysteroscope setThe smaller diameter TruClear™ 5C hysteroscope set enables a see-and-treat approach to intrauterine pathologies.
-
TruClear™ Elite hysteroscopeThe TruClear™ Elite hysteroscopes enable a see-and-treat approach for intrauterine pathologies.
-
TruClear™ hysteroscope set duoThe smallest diameter hysteroscope in the TruClear™ portfolio, TruClear™ set duo provides the option of a diagnostic or operative sheath for the office setting.
-
TruClear™ hysteroscopic tissue removal systemThe TruClear™ system offers a complete solution for diagnosing and treating intrauterine abnormalities that may be causing abnormal uterine bleeding.
Adverse effects for operative hysteroscopy include but are not limited to fluid overload due to intravasation and uterine perforation. Please refer to instructions for use (IFU) for complete contraindication and risk information. Residual risks to the patients may include but are not limited to exposure to body fluids, laceration, and carcinogen exposure.
† Compared to electrical resection
‡ Compared to MyoSure XL device
§The study was conducted in an in vitro setting created to resemble the clinical setting of operative hysteroscopy. This study's results may or may not necessarily be indictative of clinical performance.
- Hamerlynck TW, Blikkendaal MD, Schoot BC, Hanstede MM, Jansen FW. An alternative approach for removal of placental remnants: hysteroscopic morcellation. J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):796-802.
- Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps: a randomized controlled trial. Obstet Gynecol. 2014 Apr;123(4):745-51.
- Meulenbroeks D, Hamerlynck TW, Saglam-Kara 5, Van Rijssel NK, Van Vliet HA, Schoot BC. Hysteroscopic tissue systems: a randomized in vitro comparison. J Minim Invasive Gynecol. 2017; 24(1): 159-164.
- Based on preclinical internal Medtronic test report 15003596, Design validation. June 2016.
- Based on internal Medtronic test report 15001615, TruClear™ ULTRA protocol report. July 2011.